Reiberger, Thomas

Publishing since 2008 (Baby)

Has published 6 publications in 2 years

Number of publications published per year by Reiberger, Thomas. (Source : PubMed)

Distribution of publications types for Reiberger, Thomas. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.  Dig Liver Dis  2009;41;12  
•  Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.  J. Hepatol.  2009;51;5  
•  Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.  J. Viral Hepat.  2009  
•  Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.  Eur. J. Clin. Invest.  2009;39;1  
•  Reiberger T, Rasoul-Rockenschaub S, Rieger A, Ferenci P, Gangl A, Peck-Radosavljevic M. Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.  Eur. J. Clin. Invest.  2008;38;6  
•  Reiberger T, Aberle JH, Kundi M, Kohrgruber N, Rieger A, Gangl A, Holzmann H, Peck-Radosavljevic M. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.  Antivir. Ther. (Lond.)  2008;13;8  

[ See timeline ] [ See all publications ]